Name | OFTAMEDIKA, OOO |
|---|
INN | 4703124180 |
|---|
KPP | 470301001 |
|---|
OGRN | 1114703005416 |
|---|
OKPO | 90337571 |
|---|
Address | 188640, Leningradskaya Oblast', r-n Vsevolozhskiy, g. Vsevolozhsk, pr-kt Vsevolozhskiy, d. D. 17, of. KOM. 220 |
|---|
Phone | +7 (812) 332-15-28 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46 | Core activity | Wholesale of pharmaceutical goods | | 33.13 | Additional activity | Repair of electronic and optical equipment |
Registration date | 31.08.2011 |
|---|
Registering department | INSPEKTSIYA FEDERAL'NOY NALOGOVOY SLUZHBY PO VSEVOLOZHSKOMU RAYONU LENINGRADSKOY OBLASTI |
|---|
|
OFTAMEDIKA, OOO (Leningrad Oblast; INN 4703124180) was registered on 31 Aug 2011. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of OFTAMEDIKA, OOO - Limited liability companies. Form of ownership of OFTAMEDIKA, OOO - Private property. Principal activities of OFTAMEDIKA, OOO: wholesale of pharmaceutical goods (46.46), repair of electronic and optical equipment (33.13). |
Economic indicators2024
Net profit (RAS) of OFTAMEDIKA, OOO grew over 2024 1.91 times to 76.86 million RUB from 40.27 million RUB over 2023, the company informed. Revenue increased in the accounting period 1.56 times to 188.70 million RUB from 120.74 million RUB over 2023. 2023
Net profit (RAS) of OFTAMEDIKA, OOO dropped in 2023 by 24.37% to 40.27 million RUB from 53.25 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 1.53% to 120.74 million RUB from 122.61 million RUB in 2022. 2022
Net profit (RAS) of OFTAMEDIKA, OOO grew over 2022 by 41.85% to 53.25 million RUB from 37.54 million RUB over 2021, the company informed. Revenue increased in the accounting period by 18.43% to 122.61 million RUB from 103.54 million RUB over 2021. 2021
Net profit (RAS) of OFTAMEDIKA, OOO grew over 2021 by 7.15% to 37.54 million RUB from 35.03 million RUB over 2020, the company informed. Revenue increased in the accounting period by 17.00% to 103.54 million RUB from 88.49 million RUB over 2020; cost of goods sold grew by 22.77% to 58.26 million RUB from 47.45 million RUB; sales profit went up by 11.58% to 41.43 million RUB from 37.13 million RUB. 2020
Net profit (RAS) of OFTAMEDIKA, OOO dropped in 2020 by 9.14% to 35.03 million RUB from 38.56 million RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period by 3.24% to 88.49 million RUB from 91.45 million RUB in 2019; cost of goods sold decreased by 0.74% to 47.45 million RUB from 47.80 million RUB; sales profit fell by 5.80% to 37.13 million RUB from 39.42 million RUB. 2019
Net profit (RAS) of OFTAMEDIKA, OOO dropped in 2019 by 21.62% to 38.56 million RUB from 49.19 million RUB over the same period in 2018, the company informed. Revenue decreased in the accounting period by 7.23% to 91.45 million RUB from 98.58 million RUB in 2018; cost of goods sold grew by 8.28% to 47.80 million RUB from 44.15 million RUB; sales profit fell by 22.96% to 39.42 million RUB from 51.16 million RUB. 2018
Net profit (RAS) of OFTAMEDIKA, OOO grew over 2018 by 24.37% to 49.19 million RUB from 39.55 million RUB over 2017, the company informed. Revenue increased in the accounting period by 32.69% to 98.58 million RUB from 74.29 million RUB over 2017; cost of goods sold grew by 37.83% to 44.15 million RUB from 32.03 million RUB; sales profit went up by 29.67% to 51.16 million RUB from 39.45 million RUB. 2017
Net profit (RAS) of OFTAMEDIKA, OOO grew over 2017 by 42.45% to 39.55 million RUB from 27.77 million RUB over 2016, the company informed. Revenue increased in the accounting period by 20.74% to 74.29 million RUB from 61.53 million RUB over 2016; cost of goods sold grew by 26.43% to 32.03 million RUB from 25.34 million RUB; sales profit went up by 16.83% to 39.45 million RUB from 33.77 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|